Portal de Periódicos da CAPES

Dystonias and dyskinesias of the jaw associated with the use of SSRIs

1995; Wiley; Volume: 10; Issue: 3 Linguagem: Inglês

10.1002/hup.470100308

1099-1077

Kate D. Fitzgerald, David Healy,

Treatment of Major Depression

Human Psychopharmacology: Clinical and ExperimentalVolume 10, Issue 3 p. 215-219 Article Dystonias and dyskinesias of the jaw associated with the use of SSRIs K. Fitzgerald, K. Fitzgerald Academic Subdepartment of Psychological Medicine Hergest Unit, Ysbyty Gwynedd, Bangor LL57 2PW, WalesSearch for more papers by this authorD. Healy, Corresponding Author D. Healy Hergest Unit, Ysbyty Gwynedd, Bangor LL57 2PW, WalesAcademic Subdepartment of Psychological Medicine, Hergest Unit, Ysbyty Gwynedd, Bangor LL57 2PW, WalesSearch for more papers by this author K. Fitzgerald, K. Fitzgerald Academic Subdepartment of Psychological Medicine Hergest Unit, Ysbyty Gwynedd, Bangor LL57 2PW, WalesSearch for more papers by this authorD. Healy, Corresponding Author D. Healy Hergest Unit, Ysbyty Gwynedd, Bangor LL57 2PW, WalesAcademic Subdepartment of Psychological Medicine, Hergest Unit, Ysbyty Gwynedd, Bangor LL57 2PW, WalesSearch for more papers by this author First published: May/June 1995 https://doi.org/10.1002/hup.470100308Citations: 25AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References Arya, D. K. (1994). Extrapyramidal symptoms with selective serotonin reuptake inhibitors. British Journal of Psychiatry, 165, 728–733. Arya, D. K. and Szabadi, E. (1993). Dyskinesia associated with fluvoxamine. Journal of Clinical Psychopharmacology, 13, 365–366. Ashcroft, G. W., Eccleston, D. and Waddell, J. L. (1967). Recognition of amphetamine addicts. British Medical Journal, 1, 57. Baldessarini, R. J. and Marsh, E. (1990). Fluoxetine and side effects. Archives of General Psychiatry, 47, 191–192. Baldwin, D., Fineberg, N. and Montgomery, S. (1991). Fluoxetine, fluvoxamine and extrapyramidal disorders. Intrnational Clinical Psychopharmacology, 6, 51–58. Bouchard, R. H., Pourcher, E. and Vincent, P. (1989). Fluoxetine and extrapyramidal side-effects. American Journal of Psychiatry, 146, 1352–1353. Brod, T. M. (1989). Fluoxetine and extrapyramidal side effects. American Journal of Psychiatry, 146, 1353. Budman, C. L. and Bruun, R. D. (1991). Persistent dyskinesia in a patient receiving fluoxetine. American Journal of Psychiatry, 148, 1403. Burke, R. E., Fahn, S., Jankovic, J., Marsden, C. D., Lang, A. E., Gollomp, S. and Ilson, J. (1982). Tardive dystonia: late - onset and persistent dystonia caused by antipsychotic drugs. Neurology 32, 1335–1346. Creaney, W., Murray, I. and Healy, D. (1991). Antidepressant induced suicidal ideation. Human Psychopharmacology, 6, 329–332. Ellison, J. M. and Stanziani, P. (1993). SSRI-associated nocturnal bruxism in four patients. Journal of Clinical Psychiatry, 54, 432–434. Fallon, B. A. and Liebowitz, M. R. (1991). Fluoxetine and extrapyramidal symptoms in CNS lupus. Journal of Clinical Psychopharmacology, 11, 147–148. Johnson, A. M. (1992). The comparative pharmacological properties of selective serotonin re-uptake inhibitors in animals. In: Perspectives in Psychiatry, J. P. Feighner and W. F. Boyer (Eds), J. Wiley & Sons, Chichester, pp. 37–70. Korsgaard, S., Gerlach, J. and Christensson, E. (1985). Behavioural aspects of serotonin-dopamine interaction in the monkey. European Journal of Pharmacology, 118, 245–252. Lipinski, J. F., Mallya, G., Zimmerman, P. and Pope, H. G. (1989). Fluoxetine-induced akathisia: clinical and theoretical implications. Journal of Clinical Psychiatry, 50, 339–342. Magee, K. R. (1970). Bruxism related to levodopa therapy. JAMA, 214, 147. Meltzer, H. Y., Young, M., Metz, J., Fang, V. S., Schyve, P. M. and Arora, R. C. (1979). Extrapyramidal side effects and increased serum prolactin following fluoxetine, a new antidepressant. Journal of Neural Transmission, 45, 165–175. Micheli, F., Pardal, M. F., Gatto, M., Asconape, J., Giannula, R. and Parera, I. C. (1993). Bruxism secondary to chronic antidopaminergic drug exposure. Clinical Neuropharmacology, 16, 315–323. Modell, J. G. (1989). Repeated observation of yawning, clitoral engorgement and orgasm associated with fluoxetine administration. Journal of Clinical Psychopharmacology, 9, 63–65. Power, A. C. and Cowen, P. S. (1992). Fluoxetine and suicidal behaviour. Some clinical and theoretical aspects of a controversy. British Journal of Psychiatry, 161, 735–741. Reccoppa, L. Welch, W. A. and Ware, M. R. (1990). Acute dystonia and fluoxetine. Journal of Clinical Psychiatry, 51, 487. Rothschild, A. J. and Locke, C. A. (1991). Re-exposure to fluoxetine after serious suicide attempts by three patients. Journal of Clinical Psychiatry, 52, 491–493. Scheeper, B. D. M. and Rogers, D. G. (1994). Dyskinesias following treatment with 5-HT reuptake inhibitors. Journal of Psychopharmacology, 8, 258–260. Tricklebank, M. D. (1989). Interaction between dopamine and 5HT-3 receptors suggest new treatments for psychosis and drug addiction. Trends in Pharmacological Sciences, 10, 127–129. Wils, V. (1992). Extrapyramidal symptoms in a patient treated with fluvoxamine. Journal of Neurology, Neurosurgery and Psychiatry, 55, 330–331. Citing Literature Volume10, Issue3May/June 1995Pages 215-219 ReferencesRelatedInformation